122 filings
Page 4 of 7
UPLOAD
bc6dh4jb2bt9
27 May 22
Letter from SEC
12:00am
DEFA14C
ygmtvc8d07wppqwwd6sh
19 May 22
Additional information
5:23pm
8-K
l64slr1nfzctwnil0vl3
19 May 22
Other Events
5:14pm
PREC14C
lkvytgzh6gap7fyhjzl
19 May 22
Preliminary information statement in contested solicitation
5:05pm
S-8
ttt9wd 0l17md
13 May 22
Registration of securities for employees
10:25am
8-K
40f17aoc97b kg
13 May 22
Adagio Therapeutics Reports First Quarter 2022 Financial Results
7:00am
10-K/A
ihnu6
29 Apr 22
Annual report (amended)
4:43pm
DEFC14A
u4rjlp
29 Apr 22
Proxy in contested solicitation
4:02pm
PRRN14A
5jj5s50i6 gdn4l9
27 Apr 22
Revised preliminary proxy statement filed by non-management
1:13pm
PREC14A
wcoppmo0vj9ugz8ein
26 Apr 22
Preliminary proxy with contested solicitation
8:48am
PRRN14A
bhrf4 vk5t
25 Apr 22
Revised preliminary proxy statement filed by non-management
5:23pm
UPLOAD
2lup64epskv zpg4sik
18 Apr 22
Letter from SEC
12:00am
PREC14A
ojhfjl7i10
11 Apr 22
Preliminary proxy with contested solicitation
6:44am
10-K
c8cj 6rpwkmpu396x75
31 Mar 22
Annual report
8:18am
8-K
7m3evmlbz40
30 Mar 22
Results of Operations and Financial Condition
7:40am
8-K
olew6 udxqo30
21 Mar 22
Departure of Directors or Certain Officers
6:32am
8-K/A
hoz1licg93zu0bn
21 Mar 22
Departure of Directors or Certain Officers
6:30am
8-K
cd5nlzu
1 Mar 22
Departure of Directors or Certain Officers
5:07pm
8-K
wsn crpvc0v4yjsntwde
23 Feb 22
Adagio Therapeutics Announces David Hering Appointed Interim Chief Executive Officer
5:07pm